In vitro cytotoxic effects of tumor necrosis factor-α in human breast cancer cells may be associated with increased glucose consumption

FEBS Letters

Volumn 406, Issue 1-2, 1997, Pages 175-178

  Kaplan, Ofer ^a,b   Ruíz Cabello, Jesús ^c   Cohen, Jack S ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cancer cell; Glucose consumption; Nuclear magnetic resonance; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CANCER; CONCENTRATION RESPONSE; CYTOTOXICITY; GLUCOSE INTAKE; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TUMOR NECROSIS;

BREAST NEOPLASMS; CELL DIVISION; ENERGY METABOLISM; GLUCOSE; HUMANS; LACTATES; MAGNETIC RESONANCE SPECTROSCOPY; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0343990749     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)00265-2     Document Type: Article

References (27)

1. Vilcek J., Lee T.H. J Biol Chem. 266:1991;7313-7316.
2. Beyaert R., Fiers W. FEBS Lett. 340:1994;9-16.
3. Sugarman B.J., Aggarwal B.B., Hass P.E., Figari I.S., Palladino M.A., Shepard H.M. Science. 230:1985;943-945.
4. Larrick J.W., Wright S.C. FASEB J. 4:1990;3215-3223.
5. Tsujimoto M., Kip Y.K., Vilcek J. Proc Natl Acad Sci USA. 82:1985;7626-7630.
6. Ruggiero V., Latham K., Baglioni C. J Immunol. 138:1987;2711-2717.
7. Reid T.R., Torti F.M., Ringold G.M. J Biol Chem. 264:1989;4583-4589.
8. Gadian DG. Nuclear Magnetic Resonance and its Application to Living Systems. New York: Oxford University Press, 1982:1170.
9. Kaplan O., Cohen J.S. Breast Cancer Res Treat. 31:1994;285-299.
10. Soule H.D., Vasquez J., Long A., Albert S., Brennan M. J Natl Cancer Inst. 51:1973;1403-1409.
11. Shankar-Narayan K., Moress E., Chatham J.C., Barker P.B. NMR Biomed. 3:1990;23-26.
12. Kaplan O., Navon G., Lyon R.C., Faustino P.J., Straka E.J., Cohen J.S. Cancer Res. 50:1990;544-551.
13. Ben-Horin H., Tassini M., Vivi A., Navon G., Kaplan O. Cancer Res. 55:1995;2814-2821.
14. Laster S.M., Wood J.G., Gooding L.R. J Immunol. 141:1988;2629-2634.
15. Matthews N., Neale M.L., Jackson S.K., Stark J.M. Immunology. 62:1987;153-155.
16. Abbruzzesa J.L., Levin B., Ajanai J. Cancer Res. 49:1989;4057-4061.
17. Chapman P.B., Lester T.J., Casper E.S. J Clin Oncol. 5:1987;1942-1951.
18. Lienard D., Lejeune F., Delmotte J.J., Renard N., Ewalenko P. J Clin Oncol. 10:1992;52-60.
19. Sijens P.E., Eggermont A.M., van Dijk P.V., Oudkerk M. NMR Biomed. 8:1995;215-224.
20. Shine N., Palladino M.A., Patton J.S., Deisseroth A., Karczmar G.S., Matson G.B., Weiner M.W. Cancer Res. 49:1989;2123-2127.
21. Camussi G., Albano E., Tetta C., Bussolino F. Eur J Biochem. 202:1991;3-14.
22. Sierra P., Ling P.R., Istfan N.W., Bistrian B.R. Metabolism. 44:1995;1365-1370.
23. Sakurai Y., Zhang X.J., Wolfe R.R. Surgery. 117:1995;305-313.
24. Volland S., Amtmann E., Sauer G. Int J Cancer. 56:1994;698-705.
25. Cornelius P., Marlowe M., Pekala P.H. J Trauma. 30:(12 Suppl):1990;S15-20.
26. Yu N., Maciejewski-Lenoir D., Bloom F.E., Magistretti P.J. Mol Pharmacol. 48:1995;550-558.
27. Zentella A., Manogue K., Cerami A. Cytokine. 4:1993;436-447.